Captopril in congestive heart failure resistant to other vasodilators*
نویسندگان
چکیده
منابع مشابه
Vasodilators in congestive heart failure.
1. Sarnoff SJ, Berglund E: Neurohemodynamics of pulmonary edema. IV. Effect of systemic vasoconstriction and subsequent vasodilation on flow and pressures in systemic and pulmonary vascular beds. Am J Physiol 170: 588, 1952 2. Imperial ES, Levy MN, Zieske H Jr: Outflow resistance as an independent determinant of cardiac performance. Circ Res 9: 1148, 1961 3. Sonnenblick EH, Downing SE: Afterloa...
متن کاملHyponatraemia in congestive heart failure during treatment with captopril.
SHORT REPORTS Hyponatraemia in congestive heart failure during treatment with captopril The oral converting-enzyme inhibitor captopril shows promise in the treatment of cardiac failure. We used the drug in five patients with congestive heart failure that had proved unresponsive to conventional treatment and observed a clear-cut fall in plasma sodium concentration. Methods and results We studied...
متن کاملCONGESTIVE HEART FAILURE IN CHILDREN: A SURVEY OF 114 PATIENTS
During a period of four years between June, IS, 1988 to June, IS, 1992 one hundred and fourteen patients with congestive heart failure (CHF) were admitted to the pediatric department of Taleghani General Hospital. During the above period, 192 patients with heart disease were hospitalized at this department and CHF was the cause of admission in 59.4% of them. Congenital heart disease (CHO) w...
متن کاملHaemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril.
The contribution of the renin-angiotensin system to the cardiovascular response to exercise was studied in 12 patients with congestive heart failure. The haemodynamic effects of captopril were measured at rest and during supine bicycle exercise. After captopril administration, resting systemic vascular resistance fell by 26.6% and mean blood pressure by 16.7% and cardiac index increased by 19.7...
متن کاملAcute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.
Captopril (SQ 14,225), an oral angiotensin converting-enzyme inhibitor, was administered to 11 patients with severe congestive heart failure (CHF). Peak effect was observed at 1.5 hours after administration. At peak effect right atrial pressure fell from 3.4 to 0.0 mm Hg, pulmonary capillary wedge pressure (PCW) fell from 22.7 to 12.3 mm Hg, mean arterial pressure (MAP) fell from 79.5 to 62.1 m...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Heart Journal
سال: 1984
ISSN: 1522-9645,0195-668X
DOI: 10.1093/oxfordjournals.eurheartj.a061551